Harbor Capital Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40,068
| Closed | -$1.02M | – | 762 |
|
|
2024
Q1 | $1.02M | Buy |
40,068
+7,718
| +24% | +$197K | 0.13% | 207 |
|
|
2023
Q4 | $293K | Buy |
32,350
+2,336
| +8% | +$21.1K | 0.06% | 318 |
|
|
2023
Q3 | $191K | Buy |
30,014
+4,902
| +20% | +$31.3K | 0.04% | 355 |
|
|
2023
Q2 | $278K | Buy |
25,112
+2,296
| +10% | +$25.5K | 0.06% | 328 |
|
|
2023
Q1 | $350K | Sell |
22,816
-18,587
| -45% | -$285K | 0.1% | 167 |
|
|
2022
Q4 | $919K | Sell |
41,403
-891
| -2% | -$19.8K | 0.89% | 40 |
|
|
2022
Q3 | $691K | Sell |
42,294
-4,648
| -10% | -$75.9K | 0.63% | 52 |
|
|
2022
Q2 | $682K | Buy |
46,942
+1,503
| +3% | +$21.8K | 0.52% | 62 |
|
|
2022
Q1 | $839K | Sell |
45,439
-11,209
| -20% | -$207K | 0.4% | 69 |
|
|
2021
Q4 | $1.35M | Buy |
+56,648
| New | +$1.35M | 0.49% | 60 |
|